Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 4.14 -0.47 (10.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.61 | 52 Week High | $3.05 | |||
| Open | $4.60 | 52 Week Low | $0.49 | |||
| Day High | $4.65 | P/E | N/A | |||
| Day Low | $4.10 | EPS | $-1.32 | |||
| Volume | 393,346 | |||||

